Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.99K Sell
31
-9
-23% -$1.57K ﹤0.01% 385
2026
Q1
$6.82K Hold
40
﹤0.01% 316
2025
Q4
$9.02K Buy
40
+4
+11% +$870 ﹤0.01% 291
2025
Q3
$6.84K Buy
36
+9
+33% +$1.64K ﹤0.01% 366
2025
Q2
$4.25K Sell
27
-1
-4% -$151 ﹤0.01% 393
2025
Q1
$4.94K Hold
28
﹤0.01% 335
2024
Q4
$5.5K Sell
28
-1
-3% -$211 ﹤0.01% 351
2024
Q3
$6.87K Hold
29
﹤0.01% 316
2024
Q2
$6.13K Hold
29
﹤0.01% 331
2024
Q1
$7.33K Hold
29
0.01% 306
2023
Q4
$6.71K Buy
+29
New +$5.95K ﹤0.01% 300

Other funds holding IQV

Aspect Partners's IQV Position: Q2 2026 in Review

Aspect Partners reduced its IQVIA (IQV) stake by 23% in Q2 2026, selling an estimated $1.57K and leaving 31 shares worth $5.99K. The position accounts for ﹤0.01% of the portfolio, ranked #385.

Aspect Partners first reported a position in IQV in Q4 2023 and has held it in 11 quarters since. The position peaked at $9.02K in Q4 2025. 201 funds tracked by Wall St. Rank hold IQV as of Q2 2026.

  • Aspect Partners held 31 shares of IQVIA worth $5.99K as of Q2 2026.
  • Aspect Partners sold 9 IQVIA shares in Q2 2026, an estimated $1.57K.
  • IQVIA made up ﹤0.01% of Aspect Partners's portfolio in Q2 2026, its #385 holding.
  • Aspect Partners first reported a position in IQVIA in Q4 2023 and has held it in 11 quarters since.
  • Aspect Partners's IQVIA position peaked at $9.02K in Q4 2025.
  • 201 funds tracked by Wall St. Rank held IQVIA as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.